Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Good safety profile reported for darifenacin in OAB

Sep. 2, 2004

New selective beta3-adrenoceptor agonist in development at Mitsubishi

Aug. 31, 2004

Fesoterodine reduces micturition and urge incontinence in UFS

Aug. 31, 2004

Extended-release tolterodine shows efficacy for mixed incontinence in women

Aug. 31, 2004

Yamanouchi to roll out Vesicare in E.U.

Aug. 30, 2004

Orally active nonpeptide aquaretic V2 antagonist advanced to human testing

Aug. 25, 2004

Yamanouchi and Boehringer Ingelheim to copromote Flomax in U.S. for BPH

Aug. 18, 2004

Yentreve approved in E.U. for stress urinary incontinence

Aug. 18, 2004

Sanctura distribution under way

Aug. 17, 2004

Good efficacy and safety shown for long-term use of Sanctura

Aug. 4, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...